Fed. Circ. Affirms AstraZeneca Win Over $107.5M Verdict
The Federal Circuit on Thursday backed a lower court's invalidation of a pair of cancer drug patents that a jury found AstraZeneca infringed, turning back a Pfizer unit's attempt to revive...To view the full article, register now.
Already a subscriber? Click here to view full article